{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:45:09Z","timestamp":1787928309959,"version":"build-2784847793"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02274","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T14:52:12Z","timestamp":1569595932000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant"],"prefix":"10.3389","volume":"10","author":[{"given":"Jian","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-fei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-lei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-song","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/22221751.2018.1560234","article-title":"Diverse biological characteristics and varied virulence of H7N9 from Wave 5","volume":"8","author":"Bao","year":"2019","journal-title":"Emerg Microbes Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.tim.2017.06.008","article-title":"Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China","volume":"25","author":"Su","year":"2017","journal-title":"Trends Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fcimb.2018.00414","article-title":"Potential pandemic of H7N9 avian influenza A virus in human","volume":"8","author":"Pu","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3201\/eid2403.171852","article-title":"Use of influenza risk assessment tool for prepandemic preparedness","volume":"24","author":"Burke","year":"2018","journal-title":"Emerg Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/infdis\/jiw414","article-title":"Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults","volume":"214","author":"Madan","year":"2016","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1016\/j.vaccine.2015.06.047","article-title":"ISCOMATRIX adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans","volume":"33","author":"Chung","year":"2015","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/21645515.2018.1515454","article-title":"Comparative effectiveness of H7N9 vaccines in healthy individuals","volume":"15","author":"Zheng","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1016\/j.vaccine.2012.04.109","article-title":"Mucosal IgA responses in influenza virus infections; thoughts for vaccine design","volume":"30","author":"van Riet","year":"2012","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/14760584.2018.1507743","article-title":"Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics","volume":"17","author":"Sano","year":"2018","journal-title":"Expert Rev Vaccines."},{"key":"B13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in Pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front Immuno."},{"key":"B14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","article-title":"The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling","volume":"54","author":"Cai","year":"2014","journal-title":"Mol Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.1244040","article-title":"Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects","volume":"341","author":"Li","year":"2013","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12985-017-0746-0","article-title":"Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade adjuvant exacerbates viremia after virus challenge","volume":"14","author":"Van Noort","year":"2017","journal-title":"Virol J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.vaccine.2017.02.064","article-title":"Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins","volume":"35","author":"Martin","year":"2017","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.jid.2016.05.105","article-title":"Natural STING agonist as an Ideal adjuvant for cutaneous vaccination","volume":"136","author":"Wang","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/1743-422X-9-286","article-title":"Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein","volume":"9","author":"Luo","year":"2012","journal-title":"Virol J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1016\/j.vaccine.2016.11.026","article-title":"Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses","volume":"34","author":"Zheng","year":"2016","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/mi.2010.34","article-title":"Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak","volume":"3","author":"Openshaw","year":"2010","journal-title":"Mucosal Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.4161\/hv.24939","article-title":"Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design","volume":"9","author":"De Groot","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41598-017-01372-5","article-title":"A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines","volume":"7","author":"Wada","year":"2017","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"19049","DOI":"10.1038\/srep19049","article-title":"Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2017.11.030","article-title":"A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination","volume":"270","author":"Junkins","year":"2018","journal-title":"J Control Release"},{"key":"B27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0264-410X(94)90094-9","article-title":"Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice","volume":"12","author":"Tamura","year":"1994","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4005\/jjfs.92.285","article-title":"Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments","volume":"63","author":"Tamura","year":"2010","journal-title":"Jpn J Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1128\/JVI.02508-09","article-title":"Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses","volume":"84","author":"Furuya","year":"2010","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4161\/21645515.2014.995056","article-title":"Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48\/80 adjuvant","volume":"11","author":"Zheng","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00705-010-0756-3","article-title":"Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein","volume":"155","author":"Guo","year":"2010","journal-title":"Arch Virol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"125107","DOI":"10.1172\/jci.insight.125107","article-title":"The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells","volume":"4","author":"Gutjahr","year":"2019","journal-title":"JCI Insight."},{"key":"B33","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.4049\/jimmunol.159.11.5197","article-title":"CD8+ T cells clear influenza virus by perforin or Fas-dependent processes","volume":"159","author":"Topham","year":"1997","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.4049\/jimmunol.181.7.4918","article-title":"CD8 T cells utilize TRAIL to control influenza virus infection","volume":"181","author":"Brincks","year":"2008","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.4049\/jimmunol.177.5.2888","article-title":"CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch","volume":"177","author":"Brown","year":"2006","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1128\/JVI.01069-10","article-title":"Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms","volume":"84","author":"Teijaro","year":"2010","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T23:59:12Z","timestamp":1695254352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2019.02274"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02274","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"article-number":"2274"}}